Security Capital Research & Management Increases Stake in Hcp (HCP); Emergent Biosolutions (EBS) Shareholder Ubs Global Asset Management Americas Has Trimmed Its Holding by $3.33 Billion

May 23, 2018 - By Migdalia James

HCP, Inc. (NYSE:HCP) Logo

Security Capital Research & Management Inc increased its stake in Hcp Inc (HCP) by 196.42% based on its latest 2017Q4 regulatory filing with the SEC. Security Capital Research & Management Inc bought 6.21M shares as the company’s stock declined 11.22% with the market. The institutional investor held 9.37M shares of the consumer services company at the end of 2017Q4, valued at $244.44 million, up from 3.16M at the end of the previous reported quarter. Security Capital Research & Management Inc who had been investing in Hcp Inc for a number of months, seems to be bullish on the $11.08B market cap company. The stock increased 0.65% or $0.15 during the last trading session, reaching $23.25. About 1.18M shares traded. HCP, Inc. (NYSE:HCP) has declined 25.98% since May 23, 2017 and is downtrending. It has underperformed by 37.53% the S&P500.

Ubs Global Asset Management Americas Inc decreased its stake in Emergent Biosolutions Inc (EBS) by 12.96% based on its latest 2017Q4 regulatory filing with the SEC. Ubs Global Asset Management Americas Inc sold 71,713 shares as the company’s stock rose 14.08% while stock markets declined. The institutional investor held 481,807 shares of the health care company at the end of 2017Q4, valued at $22.39B, down from 553,520 at the end of the previous reported quarter. Ubs Global Asset Management Americas Inc who had been investing in Emergent Biosolutions Inc for a number of months, seems to be less bullish one the $2.54B market cap company. The stock increased 1.11% or $0.56 during the last trading session, reaching $51.04. About 80,765 shares traded. Emergent BioSolutions Inc. (NYSE:EBS) has risen 82.65% since May 23, 2017 and is uptrending. It has outperformed by 71.10% the S&P500.

Security Capital Research & Management Inc, which manages about $3.91B and $3.21B US Long portfolio, decreased its stake in Extra Space Storage Inc (NYSE:EXR) by 1.67M shares to 140,455 shares, valued at $12.28M in 2017Q4, according to the filing. It also reduced its holding in Boston Properties Inc (NYSE:BXP) by 22,739 shares in the quarter, leaving it with 426,401 shares, and cut its stake in Hudson Pac Pptys Inc (NYSE:HPP).

More news for HCP, Inc. (NYSE:HCP) were recently published by: Globenewswire.com, which released: “Report: Developing Opportunities within El Pollo Loco, Chemed, Novo Nordisk A/S, FactSet Research, Fair Isaac, and …” on May 22, 2018. Benzinga.com‘s article titled: “Raymond James Picks Welltower, Sabra Health In Underweighted Health Care REIT Sector” and published on May 21, 2018 is yet another important article.

Investors sentiment increased to 0.89 in Q4 2017. Its up 0.04, from 0.85 in 2017Q3. It improved, as 59 investors sold HCP shares while 174 reduced holdings. 51 funds opened positions while 156 raised stakes. 401.93 million shares or 2.30% less from 411.39 million shares in 2017Q3 were reported. Cipher Cap Lp invested in 0.89% or 430,239 shares. Bessemer Incorporated reported 350 shares. Jefferies Limited Liability Corp holds 0% of its portfolio in HCP, Inc. (NYSE:HCP) for 37,200 shares. Hodges Inc holds 0.02% or 8,150 shares. State Common Retirement Fund reported 1.05 million shares. Blair William And Il has 0.01% invested in HCP, Inc. (NYSE:HCP) for 51,637 shares. Washington National Bank has invested 0.05% of its portfolio in HCP, Inc. (NYSE:HCP). Exxonmobil Inv Mgmt Incorporated Tx has 0.05% invested in HCP, Inc. (NYSE:HCP). Reliance Tru Co Of Delaware owns 8,170 shares. Ledyard Comml Bank owns 5,684 shares for 0.02% of their portfolio. Guggenheim Cap Limited Liability Corporation owns 0.08% invested in HCP, Inc. (NYSE:HCP) for 1.34 million shares. Kistler, a Alabama-based fund reported 274 shares. Apg Asset Mngmt Us Inc stated it has 4.11M shares or 0.88% of all its holdings. Invesco reported 11.15 million shares. Colony Gp Limited Com accumulated 8,204 shares.

Since February 13, 2018, it had 2 insider buys, and 0 sales for $808,919 activity. Young Kendall K had bought 14,000 shares worth $306,739 on Tuesday, February 13.

Among 21 analysts covering HCP (NYSE:HCP), 5 have Buy rating, 2 Sell and 14 Hold. Therefore 24% are positive. HCP had 80 analyst reports since September 8, 2015 according to SRatingsIntel. As per Friday, December 15, the company rating was upgraded by JP Morgan. On Tuesday, November 21 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. On Friday, September 15 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. UBS downgraded the shares of HCP in report on Wednesday, March 16 to “Neutral” rating. On Sunday, August 20 the stock rating was maintained by Stifel Nicolaus with “Hold”. RBC Capital Markets maintained the shares of HCP in report on Monday, September 11 with “Hold” rating. The firm has “Underweight” rating by Barclays Capital given on Thursday, March 10. The stock of HCP, Inc. (NYSE:HCP) earned “Hold” rating by Mitsubishi UFJ Financial Group on Monday, April 24. The firm earned “Buy” rating on Monday, April 3 by Bank of America. Raymond James initiated the stock with “Underperform” rating in Tuesday, July 26 report.

Since December 12, 2017, it had 0 buys, and 7 insider sales for $4.26 million activity. Havey Adam had sold 1,898 shares worth $93,951. 7,729 Emergent BioSolutions Inc. (NYSE:EBS) shares with value of $391,787 were sold by Hauer Jerome M. Shares for $1.05 million were sold by Abdun-Nabi Daniel on Tuesday, January 2.

Investors sentiment increased to 2.02 in 2017 Q4. Its up 0.33, from 1.69 in 2017Q3. It increased, as 11 investors sold EBS shares while 53 reduced holdings. 45 funds opened positions while 84 raised stakes. 36.89 million shares or 8.80% more from 33.90 million shares in 2017Q3 were reported. Bamco Inc New York holds 0.01% or 45,000 shares. Alliancebernstein Limited Partnership holds 0% or 87,472 shares. Grantham Mayo Van Otterloo Commerce Llc accumulated 15,400 shares or 0% of the stock. Federated Inc Pa owns 490,841 shares for 0.06% of their portfolio. Aqr Mngmt Lc invested in 334,484 shares. Louisiana State Employees Retirement Systems has invested 0.03% in Emergent BioSolutions Inc. (NYSE:EBS). Howe Rusling invested 0.04% in Emergent BioSolutions Inc. (NYSE:EBS). Legal General Gru Public Ltd Liability holds 71,406 shares or 0% of its portfolio. Clark Cap Mgmt Group Incorporated has 0.11% invested in Emergent BioSolutions Inc. (NYSE:EBS). Barclays Public Limited Company reported 0% of its portfolio in Emergent BioSolutions Inc. (NYSE:EBS). Principal Fincl Grp Inc Inc has invested 0.01% in Emergent BioSolutions Inc. (NYSE:EBS). Raymond James & Associates stated it has 0% of its portfolio in Emergent BioSolutions Inc. (NYSE:EBS). Amer Gru reported 26,843 shares. Ubs Asset Management Americas stated it has 0.02% in Emergent BioSolutions Inc. (NYSE:EBS). Pnc Financial Services Grp, a Pennsylvania-based fund reported 1,365 shares.

Among 5 analysts covering Emergent Biosolutions (NYSE:EBS), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Emergent Biosolutions had 10 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co with “Hold” on Friday, July 14. The firm has “Buy” rating given on Monday, March 28 by Singular Research. Zacks upgraded Emergent BioSolutions Inc. (NYSE:EBS) rating on Monday, August 10. Zacks has “Hold” rating and $39 target. As per Friday, February 19, the company rating was initiated by Wells Fargo. The stock of Emergent BioSolutions Inc. (NYSE:EBS) earned “Hold” rating by Wells Fargo on Tuesday, April 24. Singular Research maintained Emergent BioSolutions Inc. (NYSE:EBS) on Tuesday, February 27 with “Buy” rating. Chardan Capital Markets initiated it with “Buy” rating and $47 target in Friday, April 15 report. Singular Research maintained Emergent BioSolutions Inc. (NYSE:EBS) on Tuesday, June 28 with “Buy” rating.

Ubs Global Asset Management Americas Inc, which manages about $117998.02 billion US Long portfolio, upped its stake in Ishares Tr (IEFA) by 1,954 shares to 2,415 shares, valued at $159.61M in 2017Q4, according to the filing. It also increased its holding in Mcdermott Intl Inc (NYSE:MDR) by 15,456 shares in the quarter, for a total of 438,834 shares, and has risen its stake in Mfa Mortgage Investments Inc (NYSE:MFA).

Emergent BioSolutions Inc. (NYSE:EBS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: